REGistry of Long-term AnTithrombotic TherApy-2
Recruiting · NCT04347187 · Observational (researchers observe without assigning treatment) · Lead sponsor: National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
View the official record on ClinicalTrials.gov →Interventions studied
Anticoagulants
What this trial is about
To assess the rates of ischemic and hemorrhagic complications of long-term antithrombotic therapy in patients with atrial fibrillation
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Documented atrial fibrillation with CHA2DS2VASC \> 1
Exclusion criteria
- Subjects who are unwilling or unable to provide informed consent. ACS within 12 months before inclusion Severe CHF (NYHA IV) Stroke within 6 months before inclusion Severe liver or muscle disease Severe kidney disease / renal failure with creatinine \> 3 mg/dl Conceivable impossibility to come in touch with the patient or his family at 1-year after the intervention
Where it is running
1 location listed.
- National Medical Research Center for Cardiology, Ministry of Health of Russian Federation - Moscow, Russia